Review Article

Myocardial Restoration: Is It the Cell or the Architecture or Both?

Table 1

Cell sources for Cell therapy.

Cell typesSourcesAdvantagesDisadvantagesDeliveryAnimal modelOutcomeClinical applicationMechanismReferences

Skeletal myoblastSkeletal muscleContractile, highly resistant to ischemia, large volume, autologousArrythmia, poor coupling with host tissueIntramyocardial injection, intracoronary infusionRat, sheepLVEF EDV LVSP intracoronary infusionMyogenesis Paracrine effect[4143]

Embryonic stem cell-derived CMsEmbryoLess tumorigenesis, contractile cellsEthical issue PurificationIntramyocardial injectionMouse, Rat, MonkeyLVEF EDV , Wall thickness N.AMyogenesis Paracrine effect[30, 44]

Bone marrow mononuclear cellsBone marrowAutologous, large quantityNo myogenesisIntramyocardial injection or intracoronary infusionRat, Canine, PigLVEF LVEF 0–8.1%Paracrine effect[4548]

Mesenchymal stem cellsBone marrow, cord blood, adipose tissueDifferentiate to CMs Paracrine effects Autologous Large quantityLow differentiation rateIntracoronary infusion Intramyocardial injectionRat, PigLVEF , EDV , ESV LVEF 12%, intracoronaryMyogenesis Paracrine effect[4951]

VSELsBone marrowPluripotent as embryonic stem cell AutologousSmall quantityIntracoronary delivery, Intramyocardial injectionMiceLVEF Wall thickness N.AMyogenesis Paracrine effect[52]

Cardiac Stem cellsHeart muscleContractile Paracrine effect AutologousSmall quantity Cardiac biopsy or surgical samplingIntracoronary infusion, intramyocardial injectionMice, RatLVEF ; Wall thickness YesMyogenesis Paracrine effect[26]

iPSCDermal fibroblastPluripotent, can differentiate to CMs Autologous Large quantityGene transfer TumorigenesisIntramyocardial injectionLVEF EDV ESV Cell differentiate in vitro and in vivo to CMsN.AMyogenesis Paracrine effect[53]

VSELs: very small embryonic like stem cells; iPSC: induced pluripotent stem cells; CMs: cardiomyocytes; LVEF: left ventricular ejection fraction; EDV: end diastolic volume; LVSP: left ventricular systolic pressure.